ACIXF
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyse the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.01 | $2M | $0 |
| 2025 Q4 | -0.01 | $2M | -$17M |
| 2025 Q3 | -0.01 | $2M | -$7M |
| 2025 Q2 | -0.01 | $1M | -$13M |
| 2025 Q1 | -0.01 | $2M | -$12M |
| 2024 Q4 | -0.01 | $2M | -$17M |
| 2024 Q3 | -0.02 | $993,000 | -$14M |
| 2024 Q2 | -0.02 | $2M | -$15M |